» Articles » PMID: 31209061

The Open Chromatin Landscape of Non-Small Cell Lung Carcinoma

Overview
Journal Cancer Res
Specialty Oncology
Date 2019 Jun 19
PMID 31209061
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Non-small cell lung carcinoma (NSCLC) is a major cancer type whose epigenetic alteration remains unclear. We analyzed open chromatin data with matched whole-genome sequencing and RNA-seq data of 50 primary NSCLC cases. We observed high interpatient heterogeneity of open chromatin profiles and the degree of heterogeneity correlated to several clinical parameters. Lung adenocarcinoma and lung squamous cell carcinoma (LUSC) exhibited distinct open chromatin patterns. Beyond this, we uncovered that the broadest open chromatin peaks indicated key NSCLC genes and led to less stable expression. Furthermore, we found that the open chromatin peaks were gained or lost together with somatic copy number alterations and affected the expression of important NSCLC genes. In addition, we identified 21 joint-quantitative trait loci (joint-QTL) that correlated to both assay for transposase accessible chromatin sequencing peak intensity and gene expression levels. Finally, we identified 87 regulatory risk loci associated with lung cancer-related phenotypes by intersecting the QTLs with genome-wide association study significant loci. In summary, this compendium of multiomics data provides valuable insights and a resource to understand the landscape of open chromatin features and regulatory networks in NSCLC. SIGNIFICANCE: This study utilizes state of the art genomic methods to differentiate lung cancer subtypes..

Citing Articles

Chromatin accessibility reveals potential prognostic value of the peak set associated with smoking history in patients with lung adenocarcinoma.

Liang H, Deng J, Luo T, Luo H, Li F, Wu K Heliyon. 2024; 10(24):e41006.

PMID: 39720074 PMC: 11665461. DOI: 10.1016/j.heliyon.2024.e41006.


NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to represses malignant phenotype of non-small cell lung cancer cells.

Shi K, Chen Y, Liu R, Fu X, Guo H, Gao T Cancer Cell Int. 2024; 24(1):223.

PMID: 38943137 PMC: 11212411. DOI: 10.1186/s12935-024-03414-1.


Chromatin accessibility profiling methods.

Minnoye L, Marinov G, Krausgruber T, Pan L, Marand A, Secchia S Nat Rev Methods Primers. 2024; 1.

PMID: 38410680 PMC: 10895463. DOI: 10.1038/s43586-020-00008-9.


Chromatin accessibility landscape of relapsed pediatric B-lineage acute lymphoblastic leukemia.

Wang H, Sun H, Liang B, Zhang F, Yang F, Cui B Nat Commun. 2023; 14(1):6792.

PMID: 37880218 PMC: 10600232. DOI: 10.1038/s41467-023-42565-z.


How single-cell techniques help us look into lung cancer heterogeneity and immunotherapy.

Liao P, Huang Q, Zhang J, Su Y, Xiao R, Luo S Front Immunol. 2023; 14:1238454.

PMID: 37671151 PMC: 10475738. DOI: 10.3389/fimmu.2023.1238454.